keyword
https://read.qxmd.com/read/38632238/tak1-inhibition-leads-to-ripk1-dependent-apoptosis-in-immune-activated-cancers
#1
JOURNAL ARTICLE
Helene Damhofer, Tülin Tatar, Benjamin Southgate, Scott Scarneo, Karl Agger, Daria Shlyueva, Lene Uhrbom, Gillian M Morrison, Philip F Hughes, Timothy Haystead, Steven M Pollard, Kristian Helin
Poor survival and lack of treatment response in glioblastoma (GBM) is attributed to the persistence of glioma stem cells (GSCs). To identify novel therapeutic approaches, we performed CRISPR/Cas9 knockout screens and discovered TGFβ activated kinase (TAK1) as a selective survival factor in a significant fraction of GSCs. Loss of TAK1 kinase activity results in RIPK1-dependent apoptosis via Caspase-8/FADD complex activation, dependent on autocrine TNFα ligand production and constitutive TNFR signaling...
April 17, 2024: Cell Death & Disease
https://read.qxmd.com/read/38592583/tnf-receptor-2-knockout-mouse-had-reduced-lung-cancer-growth-and-schizophrenia-like-behavior-through-a-decrease-in-trkb-dependent-bdnf-level
#2
JOURNAL ARTICLE
In Jun Yeo, Ji Eun Yu, Sung-Hyun Kim, Dae Hwan Kim, Miran Jo, Dong Ju Son, Jaesuk Yun, Sang-Bae Han, Jin Tae Hong
The relationship between schizophrenia (SCZ) and cancer development remains controversial. Based on the disease-gene association platform, it has been revealed that tumor necrosis factor receptor (TNFR) could be an important mediatory factor in both cancer and SCZ development. TNF-α also increases the expression of brain-derived neurotrophic factor (BDNF) and tropomyosin receptor kinase B (TrkB) in the development of SCZ and tumor, but the role of TNFR in mediating the association between the two diseases remains unclear...
April 9, 2024: Archives of Pharmacal Research
https://read.qxmd.com/read/38574740/tl1a-inhibition-for-inflammatory-bowel-disease-treatment-from-inflammation-to-fibrosis
#3
REVIEW
Virginia Solitano, Vipul Jairath, Federica Ungaro, Laurent Peyrin-Biroulet, Silvio Danese
The pivotal role of TL1A in modulating immune pathways crucial for inflammatory bowel disease (IBD) and intestinal fibrosis offers a promising therapeutic target. Phase 2 trials (TUSCANY and ARTEMIS-UC) evaluating an anti-TL1A antibody show progress in expanding IBD therapeutic options. First-in-human data reveal reduced expression of genes associated with extracellular matrix remodeling and fibrosis post-anti-TL1A treatment. Investigational drug TEV-48574, potentially exerting dual antifibrotic and anti-inflammatory effects, is undergoing a phase 2 basket study in both ulcerative colitis (UC) and Crohn disease (CD)...
March 26, 2024: Med
https://read.qxmd.com/read/38563230/structure-characteristics-protective-effect-and-mechanisms-of-ethanol-fractional-polysaccharides-from-dendrobium-officinale-on-acute-ethanol-induced-gastritis
#4
JOURNAL ARTICLE
Hua Zhu, Lei Xu, Peng Chen, Zhenhao Li, Wujin Yu, Peilong Sun, Jianyong Wu, Ming Cai
Gastritis is a common disease characterized by gastric ulcers and severe bleeding. Excessive daily alcohol consumption can cause acute gastritis, impacting individuals' quality of life. This study aims to explore the protective effects of different ethanol-fractional polysaccharides of Dendrobium officinale (EPDO) on acute alcohol-induced gastric injury in vivo . Results showed that EPDO-80, identified as a β-glucan, exhibited significant anti-inflammatory properties in pathology. It could reduce the area of gastric mucosal injury and cell infiltration...
April 2, 2024: Food & Function
https://read.qxmd.com/read/38539900/tnfrsf1b-signaling-blockade-protects-airway-epithelial-cells-from-oxidative-stress
#5
JOURNAL ARTICLE
Javier Checa, Pau Fiol, Marta Guevara, Josep M Aran
Progressive respiratory airway destruction due to unresolved inflammation induced by periodic infectious exacerbation episodes is a hallmark of cystic fibrosis (CF) lung pathology. To clear bacteria, neutrophils release high amounts of reactive oxygen species (ROS), which inflict collateral damage to the neighboring epithelial cells causing oxidative stress. A former genome-wide small interfering RNA (siRNA) screening in CF submucosal gland cells, instrumental for mucociliary clearance, proposed tumor necrosis factor receptor superfamily member 1B ( TNFRSF1B ; TNFR2 ) as a potential hit involved in oxidative stress susceptibility...
March 18, 2024: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/38538662/circulating-tnf-receptor-levels-are-associated-with-estimated-glomerular-filtration-rate-even-in-healthy-individuals-with-normal-kidney-function
#6
JOURNAL ARTICLE
Tomohito Gohda, Maki Murakoshi, Terumi Shibata, Yusuke Suzuki, Hiroyuki Takemura, Koji Tsuchiya, Tomoki Okada, Mitsuru Wakita, Yuki Horiuchi, Yoko Tabe, Nozomu Kamei
The association between serum tumor necrosis factor receptor (TNFRs: TNFR1, TNFR2) levels and estimated glomerular filtration rate (eGFR) observed in patients with diabetes has not been comprehensively tested in healthy subjects with normal kidney function. It also remains unclear whether TNFR levels differ by age and sex, and between healthy subjects and diabetics. We measured serum TNFR levels in 413 healthy subjects and 292 patients with type 2 diabetes. In healthy subjects, TNFR levels did not differ between men and women...
March 27, 2024: Scientific Reports
https://read.qxmd.com/read/38526805/ox40-ox40-ligand-and-its-role-in-precision-immune-oncology
#7
REVIEW
Bicky Thapa, Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mary K Nesline, Rebecca A Previs, Jeffery M Conroy, Paul DePietro, Sarabjot Pabla, Razelle Kurzrock
Immune checkpoint inhibitors have changed the treatment landscape for various malignancies; however, their benefit is limited to a subset of patients. The immune machinery includes both mediators of suppression/immune evasion, such as PD-1, PD-L1, CTLA-4, and LAG-3, all of which can be inhibited by specific antibodies, and immune-stimulatory molecules, such as T-cell co-stimulatory receptors that belong to the tumor necrosis factor receptor superfamily (TNFRSF), including OX40 receptor (CD134; TNFRSF4), 4-1BB (CD137; TNFRSF9), and glucocorticoid-induced TNFR-related (GITR) protein (CD357; TNFRSF18)...
March 25, 2024: Cancer Metastasis Reviews
https://read.qxmd.com/read/38500108/modulation-of-hippocampal-protein-expression-by-a-brain-penetrant-biologic-tnf-%C3%AE-inhibitor-in-the-3xtg-alzheimer-s-disease-mice
#8
JOURNAL ARTICLE
Nataraj Jagadeesan, G Chuli Roules, Devaraj V Chandrashekar, Joshua Yang, Sanjana Kolluru, Rachita K Sumbria
BACKGROUND: Biologic TNF-α inhibitors (bTNFIs) can block cerebral TNF-α in Alzheimer's disease (AD) if these macromolecules can cross the blood-brain barrier (BBB). Thus, a model bTNFI, the extracellular domain of type II TNF-α receptor (TNFR), which can bind to and sequester TNF-α, was fused with a mouse transferrin receptor antibody (TfRMAb) to enable brain delivery via BBB TfR-mediated transcytosis. Previously, we found TfRMAb-TNFR to be protective in a mouse model of amyloidosis (APP/PS1) and tauopathy (PS19), and herein we investigated its effects in mice that combine both amyloidosis and tauopathy (3xTg-AD)...
March 18, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38481996/serum-high-mobility-group-box-1-as-a-potential-biomarker-for-the-progression-of-kidney-disease-in-patients-with-type-2-diabetes
#9
JOURNAL ARTICLE
Tongtong Liu, Hailing Zhao, Ying Wang, Peng Qu, Yanmei Wang, Xiai Wu, Tingting Zhao, Liping Yang, Huimin Mao, Liang Peng, Yongli Zhan, Ping Li
BACKGROUND: As a damage-associated molecular pattern protein, high mobility group box 1 (HMGB1) is associated with kidney and systemic inflammation. The predictive and therapeutic value of HMGB1 as a biomarker has been confirmed in various diseases. However, its value in diabetic kidney disease (DKD) remains unclear. Therefore, this study aimed to investigate the correlation between serum and urine HMGB1 levels and DKD progression. METHODS: We recruited 196 patients with type 2 diabetes mellitus (T2DM), including 109 with DKD and 87 T2DM patients without DKD...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38465914/inflammatory-markers-in-pregnancy-are-associated-with-postpartum-weight-in-south-african-women-living-with-hiv-on-antiretroviral-therapy
#10
JOURNAL ARTICLE
Hlengiwe P Madlala, Landon Myer, Hayli Geffen, Jody Rusch, Muki S Shey, Demi Meyer, Julia H Goedecke, Thokozile R Malaba, Clive M Gray, Marie-Louise Newell, Jennifer Jao
BACKGROUND: Postpartum weight (PPW) contributes to long-term obesity, a growing concern in persons with HIV (PWH). We investigated whether inflammatory markers in pregnancy may be involved in postpartum (PP) obesity in PWH. SETTING: A total of 57 pregnant PWH enrolled at ≤14 weeks gestation (T1) in Gugulethu antenatal care clinic in Cape Town and followed through 48 weeks PP were included. METHODS: Plasma soluble (s) CD14, sCD163, leptin, tumour necrosis factor receptor 1 (TNFR-1), resistin, adiponectin, and interleukin-6 (IL-6) were assayed in duplicate using the Luminex platform...
March 4, 2024: Journal of Acquired Immune Deficiency Syndromes: JAIDS
https://read.qxmd.com/read/38463638/inflammation-endothelial-injury-and-the-acute-respiratory-distress-syndrome-after-out-of-hospital-cardiac-arrest
#11
JOURNAL ARTICLE
Sarah C Katsandres, Jane Hall, Kyle Danielson, Sana Sakr, Sarah G Dean, David J Carlbom, Mark M Wurfel, Pavan K Bhatraju, Joseph A Hippensteel, Eric P Schmidt, Kaori Oshima, Catherine R Counts, Michael R Sayre, Daniel J Henning, Nicholas J Johnson
BACKGROUND: Acute respiratory distress syndrome (ARDS) is often seen in patients resuscitated from out-of-hospital cardiac arrest (OHCA). We aim to test whether inflammatory or endothelial injury markers are associated with the development of ARDS in patients hospitalized after OHCA. METHODS: We conducted a prospective, cohort, pilot study at an urban academic medical center in 2019 that included a convenience sample of adults with non-traumatic OHCA. Blood and pulmonary edema fluid (PEF) were collected within 12 hours of hospital arrival...
March 2024: Resuscitation plus
https://read.qxmd.com/read/38437728/targeting-the-tnf-iap-pathway-synergizes-with-anti-cd3-immunotherapy-in-t-cell-acute-lymphoblastic-leukemia
#12
JOURNAL ARTICLE
Andrea Ávila Ávila, Kanokporn Nuantang, Mariana Lobato Oliveira, Sabine Druillennec, Benedetta Zaniboni, Etienne Lengliné, Vahid Asnafi, Jacques Ghysdael, Christine Tran Quang
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy. Current treatments, based on intensive chemotherapy regimens provide overall survival rates of ~85% in children and <50% in adults, calling the search of new therapeutic options. We previously reported that targeting the T cell receptor (TCR) in T-ALL with anti-CD3 (CD3) mAbs enforces a molecular program akin to thymic negative selection, a major developmental checkpoint in normal T-cell development, induces leukemic cell death and impairs leukemia progression to ultimately improve host survival...
March 4, 2024: Blood
https://read.qxmd.com/read/38404743/deciphering-the-synthetic-and-refolding-strategy-of-a-cysteine-rich-domain-in-the-tumor-necrosis-factor-receptor-tnf-r-for-racemic-crystallography-analysis-and-d-peptide-ligand-discovery
#13
JOURNAL ARTICLE
Alexander J Lander, Yifu Kong, Yi Jin, Chuanliu Wu, Louis Y P Luk
Many cell-surface receptors are promising targets for chemical synthesis because of their critical roles in disease development. This synthetic approach enables investigations by racemic protein crystallography and ligand discovery by mirror-image methodologies. However, due to their complex nature, the chemical synthesis of a receptor can be a significant challenge. Here, we describe the chemical synthesis and folding of a central, cysteine-rich domain of the cell-surface receptor tumor necrosis factor 1 which is integral to binding of the cytokine TNF-α, namely, TNFR-1 CRD2...
February 21, 2024: ACS Bio Med Chem Au
https://read.qxmd.com/read/38403541/association-of-lipoprotein-a-with-peri-coronary-inflammation-in-persons-with-and-without-hiv-infection
#14
JOURNAL ARTICLE
Erin Zisman, Mian Hossain, Nicholas T Funderburg, Robert Christenson, Jean Jeudy, Shana Burrowes, Allison G Hays, Nivya George, Michael L Freeman, Heather Rebuck, Sarah E Mitchell, Michael Miller, Shashwatee Bagchi
BACKGROUND: Persons with HIV (PWH) have an increased risk of developing cardiovascular disease (CVD) compared to persons without HIV (PWoH). Lipoprotein a (Lp(a)) is a known atherosclerotic risk factor in PWoH, but there are no studies investigating Lp(a) and peri-coronary inflammation. OBJECTIVE: To investigate whether Lp(a) is associated with peri-coronary inflammation as assessed by the fat attenuation index (FAI) and activated monocytes and T lymphocytes in PWH and PWoH...
February 15, 2024: Journal of Clinical Lipidology
https://read.qxmd.com/read/38364733/emerging-role-and-mechanism-of-hace1-in-the-pathogenesis-of-neurodegenerative-diseases-a-promising-target
#15
REVIEW
Caixia Zang, Hui Liu, Jingwen Ning, Qiuzhu Chen, Yueqi Jiang, Meiyu Shang, Yang Yang, Jingwei Ma, Yirong Dong, Jinrong Wang, Fangfang Li, Xiuqi Bao, Dan Zhang
HACE1 is a member of the HECT domain-containing E3 ligases with 909 amino acid residues, containing N-terminal ankyrin-repeats (ANK) and C-terminal HECT domain. Previously, it was shown that HACE1 is inactive in human tumors and plays a crucial role in the initiation, progression, and invasion of malignant tumors. Recent studies indicated that HACE1 might be closely involved in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. HACE1 interacts with its substrates, including Ras-related C3 botulinum toxin substrate 1 (Rac1), nuclear factor erythroid 2-related factor 2 (Nrf2), tumor necrosis factor receptor (TNFR), and optineurin (OPTN), through which participates in several pathophysiological processes, such as oxidative stress, autophagy and inflammation...
February 15, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38354704/signaling-via-a-cd27-traf2-shp-1-axis-during-naive-t%C3%A2-cell-activation-promotes-memory-associated-gene-regulatory-networks
#16
JOURNAL ARTICLE
Carla A Jaeger-Ruckstuhl, Yun Lo, Elena Fulton, Olivia G Waltner, Tamer B Shabaneh, Sylvain Simon, Pranav V Muthuraman, Colin E Correnti, Oliver J Newsom, Ian A Engstrom, Sami B Kanaan, Shruti S Bhise, Jobelle M C Peralta, Raymond Ruff, Jason P Price, Sylvia M Stull, Andrew R Stevens, Grace Bugos, Mitchell G Kluesner, Valentin Voillet, Vishaka Muhunthan, Fionnuala Morrish, James M Olson, Raphaël Gottardo, Jay F Sarthy, Steven Henikoff, Lucas B Sullivan, Scott N Furlan, Stanley R Riddell
The interaction of the tumor necrosis factor receptor (TNFR) family member CD27 on naive CD8+ T (Tn) cells with homotrimeric CD70 on antigen-presenting cells (APCs) is necessary for T cell memory fate determination. Here, we examined CD27 signaling during Tn cell activation and differentiation. In conjunction with T cell receptor (TCR) stimulation, ligation of CD27 by a synthetic trimeric CD70 ligand triggered CD27 internalization and degradation, suggesting active regulation of this signaling axis...
February 13, 2024: Immunity
https://read.qxmd.com/read/38341821/selective-targeting-or-reprogramming-of-intra-tumoral-tregs
#17
REVIEW
Keywan Mortezaee
Regulatory T cells (Tregs) are critical immunosuppressive cells that are frequently present in the tumor microenvironment of solid cancers and enable progression of tumors toward metastasis. The cells expand in response to tumor-associated antigens and are actively involved in bypassing immunotherapy with immune checkpoint inhibitors through integrating numerous environmental signals. A point here is that Tregs are clonally distinct in peripheral blood from tumor area. Currently, an effective and novel task in cancer immunotherapy is to selectively destabilize or deplete intra-tumoral Tregs in order to avoid systemic inflammatory events...
February 11, 2024: Medical Oncology
https://read.qxmd.com/read/38286453/-mechanism-of-shikonin-on-spinal-cord-injury-in-rats-based-on-tnfr-ripk1-pathway
#18
JOURNAL ARTICLE
Ji-Sheng Shi, Ji-Ze Qina, Jin-Guang Wang, Bin Lin, Tong-Tao Pang
OBJECTIVE: To explore the effect of shikonin on the recovery of nerve function after acute spinal cord injury(SCI) in rats. METHODS: 96 male Sprague-Dawley(SD)rats were divided into 4 groups randomly:sham operation group (Group A), sham operation+shikonin group (Group B), SCI+ DMSO(Group C), SCI+shikonin group (Group D).The acute SCI model of rats was made by clamp method in groups C and D . After subdural catheterization, no drug was given in group A. rats in groups B and D were injected with 100 mg·kg-1 of shikonin through catheter 30 min after modeling, and rats in group C were given with the same amount of DMSO, once a day until the time point of collection tissue...
January 25, 2024: Zhongguo Gu Shang, China Journal of Orthopaedics and Traumatology
https://read.qxmd.com/read/38243600/preclinical-evaluation-of-a-novel-car-t-therapy-utilizing-a-scfv-antibody-highly-specific-to-mage-a4-p230-239-hla-a-02-01-complex
#19
JOURNAL ARTICLE
Linan Wang, Masahiro Matsumoto, Yasushi Akahori, Naohiro Seo, Kazuko Shirakura, Takuma Kato, Yoichi Katsumoto, Yoshihiro Miyahara, Hiroshi Shiku
Despite the revolutionary success of chimeric antigen receptor (CAR)-T therapy for hematological malignancies, successful CAR-T therapies for solid tumors remain limited. One major obstacle is the scarcity of tumor-specific cell surface molecules. One potential solution to overcome this barrier is to utilize antibodies that recognize peptide/MHC complexes in a T-cell receptor (TCR)-like fashion, allowing CAR-T cells to recognize intracellular tumor antigens. This study reports a highly specific scFv antibody against the MAGE-A4p230-239 /HLA-A*02:01 complex (MAGE-A4 pMHC), screened from a human scFv phage display library...
January 18, 2024: Molecular Therapy
https://read.qxmd.com/read/38203454/protective-effects-of-sophoraflavanone-g-by-inhibiting-tnf-%C3%AE-induced-mmp-9-mediated-events-in-brain-microvascular-endothelial-cells
#20
JOURNAL ARTICLE
Tsong-Hai Lee, Jiun-Liang Chen, Ming-Ming Tsai, Yi-Hsuan Wu, Hui-Ching Tseng, Li-Ching Cheng, Velayuthaprabhu Shanmugam, Hsi-Lung Hsieh
The regulation of matrix metalloproteinases (MMPs), especially MMP-9, has a critical role in both physiological and pathological events in the central nervous system (CNS). MMP-9 is an indicator of inflammation that triggers several CNS disorders, including neurodegeneration. Tumor necrosis factor-α (TNF-α) has the ability to stimulate the production of different inflammatory factors, including MMP-9, in several conditions. Numerous phytochemicals are hypothesized to mitigate inflammation, including the CNS...
December 24, 2023: International Journal of Molecular Sciences
keyword
keyword
19544
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.